Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8313353rdf:typepubmed:Citationlld:pubmed
pubmed-article:8313353lifeskim:mentionsumls-concept:C0007090lld:lifeskim
pubmed-article:8313353lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8313353lifeskim:mentionsumls-concept:C0035804lld:lifeskim
pubmed-article:8313353lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:8313353lifeskim:mentionsumls-concept:C0444956lld:lifeskim
pubmed-article:8313353lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:8313353pubmed:issue3lld:pubmed
pubmed-article:8313353pubmed:dateCreated1994-3-21lld:pubmed
pubmed-article:8313353pubmed:abstractTextGuidelines for the conduct of rodent carcinogenicity studies stipulate that when the test substance is administered via the diet, its concentration need not exceed 5% of the diet. Since it is now apparent that human carcinogens are amongst the most potent of rodent carcinogens, it should be possible to detect accurately potential human carcinogens by using only relatively low dose levels in rodent studies. Our analysis of the potency of human carcinogens in rodent studies leads to the conclusion that, even after applying a safety factor of 10, there is no purpose in using dose levels higher than 500 mg/kg body weight or 1% in the diet.lld:pubmed
pubmed-article:8313353pubmed:languageenglld:pubmed
pubmed-article:8313353pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8313353pubmed:citationSubsetIMlld:pubmed
pubmed-article:8313353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8313353pubmed:statusMEDLINElld:pubmed
pubmed-article:8313353pubmed:monthDeclld:pubmed
pubmed-article:8313353pubmed:issn0304-3835lld:pubmed
pubmed-article:8313353pubmed:authorpubmed-author:DaviesT STSlld:pubmed
pubmed-article:8313353pubmed:authorpubmed-author:MonroAAlld:pubmed
pubmed-article:8313353pubmed:issnTypePrintlld:pubmed
pubmed-article:8313353pubmed:day20lld:pubmed
pubmed-article:8313353pubmed:volume75lld:pubmed
pubmed-article:8313353pubmed:ownerNLMlld:pubmed
pubmed-article:8313353pubmed:authorsCompleteYlld:pubmed
pubmed-article:8313353pubmed:pagination183-94lld:pubmed
pubmed-article:8313353pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:8313353pubmed:meshHeadingpubmed-meshheading:8313353-...lld:pubmed
pubmed-article:8313353pubmed:meshHeadingpubmed-meshheading:8313353-...lld:pubmed
pubmed-article:8313353pubmed:meshHeadingpubmed-meshheading:8313353-...lld:pubmed
pubmed-article:8313353pubmed:meshHeadingpubmed-meshheading:8313353-...lld:pubmed
pubmed-article:8313353pubmed:meshHeadingpubmed-meshheading:8313353-...lld:pubmed
pubmed-article:8313353pubmed:meshHeadingpubmed-meshheading:8313353-...lld:pubmed
pubmed-article:8313353pubmed:meshHeadingpubmed-meshheading:8313353-...lld:pubmed
pubmed-article:8313353pubmed:meshHeadingpubmed-meshheading:8313353-...lld:pubmed
pubmed-article:8313353pubmed:meshHeadingpubmed-meshheading:8313353-...lld:pubmed
pubmed-article:8313353pubmed:meshHeadingpubmed-meshheading:8313353-...lld:pubmed
pubmed-article:8313353pubmed:meshHeadingpubmed-meshheading:8313353-...lld:pubmed
pubmed-article:8313353pubmed:year1993lld:pubmed
pubmed-article:8313353pubmed:articleTitleHigh dose levels are not necessary in rodent studies to detect human carcinogens.lld:pubmed
pubmed-article:8313353pubmed:affiliationPfizer Central Research, Groton, CT 06340.lld:pubmed
pubmed-article:8313353pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8313353pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8313353lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8313353lld:pubmed